Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
adidas (ADDYY) shows signs of operational stabilization: a reasonable P/E of 18, falling short interest, improving technical momentum, and a market cap of about $28.9B that does not fully reflect the recovery in fundamentals. We upgrade to a tactical long with entry at $80.19, a stop at $76.00, and a primary target of $95.00 over a position horizon…
Quantum BioPharma Ltd. has submitted an Investigational New Drug (IND) application to the FDA for Lucid-MS, a novel therapeutic candidate targeting demyelination in multiple sclerosis (MS). This milestone supports the planned Phase 2 clinical trial aimed at evaluating Lucid-MS's efficacy and safety, representing a significant step forward in Quantu…
Stellantis N.V. has announced that the live webcast link for its 2026 Annual General Meeting, scheduled on April 14, 2026, will be available on its corporate website. The company highlights its portfolio of automotive brands and invites stakeholders to follow the event online.
Nvidia's leadership in AI datacenter GPUs, massive free cash flow and improving adoption tailwinds make the case for a multi-trillion-dollar revaluation. This trade idea outlines a long-term long position with a $400 target over ~180 trading days, a clear stop, and the catalysts and risks that could push shares toward a higher valuation.
Nordic American Tankers (NAT) offers a compelling risk-reward for long-term investors: expanding Suezmax fleet, a recently raised dividend (30%), insider buying, and a lean float with occasional heavy short interest. Enter at $5.88, hold through 180 trading days, target $8.00 with a $4.60 stop.
Stryker, a global medical technology company, announced it will release its fiscal year 2026 first quarter financial results on April 30, 2026. The company will issue a press release with summary financials and host a webcast to discuss the performance. The announcement provides investors with a scheduled update but does not contain new financial d…
CareCloud, Inc. announced its presentation at the 2026 AAPPR Annual Conference to showcase Marketware, its AI-powered physician recruitment platform. The platform aims to accelerate hiring, improve recruitment data visibility, and deliver measurable ROI by integrating recruitment, analytics, and onboarding functions. CareCloud highlights Marketware…
Axe Compute Inc. announced the signing of approximately $12 million in executed agreements in the last 30 days, resulting in an estimated $835 thousand monthly income entering Q2 2026. This level of contracted revenue underscores growing demand for the company’s GPU infrastructure services supporting AI workloads. The agreements reflect recurring, …
Genius Group Limited (NYSE American: GNS) announced robust first quarter 2026 operational results, including a 171% year-over-year revenue increase to $3.3 million and a net operating profit of $2.7 million, reversing a prior year loss. The company attributes growth to all three business units—Genius School, Genius Academy, and Genius Resorts—and s…
Futures tied to Canada’s main equity gauge ticked upward on Wednesday as investor sentiment improved on reports suggesting a possible swift end to the conflict involving Iran. The S&P/TSX 60 futures climbed modestly, supported in part by gold’s advance, while U.S. futures also rose. Market moves followed media reports and statements from political …
Lotus Technology Inc., a global leader in luxury electric vehicles and advanced mobility technologies, announced it will release its unaudited Q4 and full year 2025 financial results on April 10, 2026. The company will hold a conference call and webcast for investors to discuss the results.
Curis INC director Kenneth I. Kaitin purchased 10,000 common shares on March 31, 2026, investing $5,487 at $0.5487 per share. The acquisition comes while the stock trades near its 52-week low of $0.50 and following a reported Q4 2025 net income of $19.4 million driven by a one-time gain from the sale of royalty rights. After the transaction, Kaitin…
Coca-Cola and its two authorized bottlers - Coca-Cola Beverages South Africa and Coca-Cola Peninsula Beverages - announced plans to invest 17.6 billion rand (about $1.05 billion) in South Africa through 2030. The company said the funds will back expanded production capacity, strengthen distribution networks and accelerate innovation across the Coca…
Kayne Anderson Energy Infrastructure Fund, trading on NYSE under the ticker KYN, announced a monthly distribution of $0.085 per share payable on April 30, 2026. The distribution reflects an estimated 50% return of capital portion and aligns with the Fund's objective to provide high after-tax total returns primarily via cash distributions. Payments …
Nexera Technologies Ltd reported a 23% revenue increase to $16.83 million for the full year 2025, driven by a strong second half performance of $9.85 million. The company has successfully integrated its logistics segment Pure Logistics and is strategically repositioning towards AI-powered homeland security solutions, underpinned by a corporate rebr…
Applications to sell newer nicotine pouch products in the United States remain unresolved even under a Food and Drug Administration pilot fast-track programme, as agency reviewers have raised questions about risks to non-users and young people. The delays affect major tobacco firms and come despite strong sales for existing pouch brands and industr…
Barclays upgraded Danish offshore wind developer Ørsted to equal weight from underweight and increased its price target to DKK 160 from DKK 117, citing a sharply improved balance sheet following a 2025 rights issue and an accelerated disposal programme. The broker highlights a substantial drop in net debt, forecasts rising EBITDA and adjusted EPS o…
A poll of nearly 70 foreign-exchange strategists conducted March 27-April 1 indicates the U.S. dollar's modest uptick since the outbreak of the U.S.-Israeli war on Iran will likely fade. Analysts point to an erosion in the dollar's safe-haven appeal, higher Treasury yields, a slide in gold and broader market dynamics - including oil price moves and…
Goldman Sachs argues that recent market bets on Federal Reserve rate hikes following the Iran conflict overstate the risk that rising oil prices will force tighter U.S. monetary policy. Analyst Manuel Abecasis points to a narrower supply shock, a less oil-dependent economy, easing labor market pressures, anchored inflation expectations, and already…
Memory chip shares fell sharply over a recent two-week stretch, with Micron, SK Hynix and Samsung Electronics down roughly 30%, 24% and 20% respectively. Jeff Kim, head of research at KB Securities, argues the pullback reflects exaggerated concerns rather than weakening fundamentals, pointing to rising AI data-center capital expenditure in 2026, st…
Sharon AI Holdings Inc. (NASDAQ:SHAZ) saw its stock surge 30% after announcing a five-year, $1.25 billion AI cloud infrastructure contract with ESDS Software Solutions Ltd. The deal calls for deployment of an 8,000-unit B300 cluster at an existing Australian data center provider, with revenue expected to commence in the third quarter of 2026 and an…
Shares of Target Hospitality Corp. jumped 25% on Wednesday after the company announced a multi-year contract worth more than $550 million to provide modular workforce accommodations for a data center development in North Texas. The deal calls for a purpose-built community to house roughly 4,000 people, with construction starting immediately and sta…
Alcoa (AA) is benefiting from a global aluminum supply squeeze, attractive earnings and cash-flow metrics, and a modestly valued enterprise. I recommend a long trade with a $68.00 entry, $82.00 target and $60.00 stop, sized for a medium-risk portfolio and held over the next 180 trading days while catalysts play out.
Insmed's market cap sits around $35 billion while revenue expectations are still ramping. Recent FDA approval of BRINSUPRI and an advancing inhaled treprostinil program mean the company is finally building commercial scale. This trade idea bets the pipeline execution and near-term catalysts will push the stock higher, while recognizing the balance …
Trevi Therapeutics, a clinical-stage biopharmaceutical company developing Haduvio™ for treating chronic cough associated with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (ILD), and refractory chronic cough (RCC), announced senior management participation in key upcoming healthcare and biotech investor conferences. These e…
